AI: Transforming Cancer Care - Early Detection, Personalized Therapies, and a Brighter Future

Artificial Intelligence in Cancer Diagnosis and Therapy Market Assessment worth $ 5.62 Billion by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial Intelligence in Cancer Diagnosis and Therapy Market- by Surgery Type (Radiotherapy,

Chemotherapy, Immunotherapy, Precision Therapy, Phototherapy, Gene Therapy, and Sonodynamic Therapy), Cancer Type (Breast Cancer, Lung Cancer, Melanoma Cancer, Colorectal Cancer, Prostate Cancer, and Others), End-Use (Hospitals, Cancer Research Centre, and Diagnostic Labs), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2031."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1294

InsightAce Analytic's latest research offers a beacon of hope in the fight against cancer. The global market for artificial intelligence (AI) in cancer diagnosis and therapy is expected to surge from US$548.11 million in 2021 to a staggering US$5.62 billion by 2030, reflecting a remarkable compound annual growth rate (CAGR) of 30.1% between 2024 and 2031.

Cancer, a leading cause of death globally, arises from abnormal cell growth. Early detection and treatment are paramount in improving patient outcomes. This is where AI steps in, holding immense potential to revolutionize both cancer diagnosis and therapy. AI, a branch of computer science focused on mimicking human intelligence in machines, plays a crucial role in various aspects of cancer care.

AI-powered systems excel at identifying patterns in data that might escape the human eye. These systems can even predict cancer initiation and spread, empowering healthcare professionals with valuable insights. In cancer diagnosis, AI can analyze medical images with exceptional precision, detecting minute anomalies that could be missed by human specialists. Furthermore, AI is making waves in drug discovery and personalized treatment plans for cancer patients.

One of the main drivers propelling the growth of this market is the increase in demand for precision medicine and early cancer detection, as well as the emergence of very sophisticated AI systems. Cancer is one of the significant causes of mortality worldwide. According to the same source, low- and middle-income nations account for roughly 70% of all cancer-related fatalities.

Therefore, one of the key reasons anticipated to propel this market's growth over the forecast period is the rising incidence of cancer. The development of multidisciplinary platforms and advancements in prognosis accuracy using cutting-edge AI and Machine Learning (ML) methods have increased the accuracy of cancer susceptibility, recurrence, and cancer prediction.

These factors are the main drivers of AI in cancer diagnosis and therapy market revenue growth.

North America is anticipated to be the major contributor to the Artificial Intelligence in Cancer Diagnosis and Therapy market over the forecast years. This region's substantial share can be attributable to the presence of essential market players and the rising prevalence of cancer. According to the American Cancer Society, around 1,762,450 new cancer cases are predicted to be diagnosed in 2019, with 606,880 individuals dying from cancer in the United States.

To combat this issue, the region is actively deploying AI. Cancer tumour profiling has significantly increased clinical and research uses in this region. In addition, the Asia Pacific Artificial Intelligence in Cancer Diagnosis and Therapy market is expected to grow considerably during the forecast period because of increased investment in AI healthcare startups, more significant usage of AI in sickness diagnosis, and its ability to provide numerous areas of patient care.

Major market players operating in the Artificial Intelligence in Cancer Diagnosis and Therapy market include
Pfizer Inc., Therapixel, Sophia Genetics, Janssen Global Services, LLC., PathAI, IBM, Microsoft, Oracle, OncoHealth, and Ancora Medical.

Recent collaborations and agreements in the market:
• In September 2021, The Center for Devices and Radiological Health of the Digital Health Center of Excellence released the Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. The FDA's Center for Devices and Radiological Health (CDRH) recommends comprehensive regulations for these technologies based on the entire product lifecycle. These regulations will allow modifications based on learning and adaptation from real-world experience while maintaining the safety and efficacy of software as a medical device.

• In January 2021, A cooperation agreement for the AI-driven clinical interpretation platform ClinOme was struck by 4baseCare, a Precision Oncology startup backed by Illumina Accelerator and the Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC) - Tata Memorial Centre. Through this collaboration, it will be possible for clinicians to offer patients with cancer-tailored treatment plans by developing a native platform that delivers data insights and streamlined reports.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1294

Market Segments
Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Surgery Type, 2022-2030 (Value US$ Mn)
• Radiotherapy
• Chemotherapy
• Immunotherapy
• Precision Therapy
• Phototherapy
• Gene Therapy
• Sonodynamic Therapy

Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Cancer Type, 2022-2030 (Value US$ Mn)
• Breast Cancer
• Lung Cancer
• Melanoma Cancer
• Colorectal Cancer
• Prostate Cancer
• Others

Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by End-Use, 2022-2030 (Value US$ Mn)
• Hospitals
• Cancer Research Center
• Diagnostic Labs

Global Artificial Intelligence in Cancer Diagnosis and Therapy Market, by region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada

Europe Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Artificial Intelligence in Cancer Diagnosis and Therapy Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Artificial Intelligence in Cancer Diagnosis and Therapy market
 To receive an industry overview and future trends of the Artificial Intelligence in Cancer Diagnosis and Therapy market
 To analyze the Artificial Intelligence in Cancer Diagnosis and Therapy market drivers and challenges
 To get information on the Artificial Intelligence in Cancer Diagnosis and Therapy market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Artificial Intelligence in Cancer Diagnosis and Therapy market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1294

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.